This pioneering guideline, led by drs. “depending on the extent, stability, and location of vitiligo, treatment can range from topical creams and nutritional changes to phototherapy and systemic immunosuppressives, as well as surgical options for some types of vitiligo,” iltefat hamzavi, md, told practical dermatology.
A supplemental new drug application for ruxolitinib cream in vitiligo is currently under priority review by the fda, with a prescription drug user fee act target action date of july 18, 2022. A new vitiligo treatment development has been reported at the 2024 american academy of dermatology (aad) annual meeting in san diego, california, as outlined in a recent article in dermatology times.
Vitiligo Is A Condition That Causes Your Skin To Lose Its Colour Or Pigment.
Vitiligo disrupts pigment production, leading to white patches on the skin.
+61 3 9660 4900 Fax:
The appraisal was discussed by the technology appraisal committee on 11th january 2024.
Images References :
Dr Viktoria Eleftheriadou Discusses Recent Progress And The Future Trajectory Of Vitiligo Treatment, Including The Approval Of Ruxolitinib.
Vitiligo is a skin condition causing discoloration due to a lack of melanocytes, the specialised skin cells that produce melanin which is responsible for imparting colour to the skin, hair and eyes.
Vitiligo Is A Condition That Causes Your Skin To Lose Its Colour Or Pigment.
A supplemental new drug application for ruxolitinib cream in vitiligo is currently under priority review by the fda, with a prescription drug user fee act target action date of july 18, 2022.